Conference 2016: From Drug Discovery to Health Outcomes: Population to Patient May 31 - June 3, 2016 River Rock Resort, Richmond, BC Canada A joint conference of: Canadian Society for Pharmaceutical Sciences Canadian Chapter of Controlled Release Society Conference Chair: Frank Abbott, University of British Columbia, Vancouver, BC Conference Organizing Committee: Michael Coughtrie (UBC), Jason Crawford (Centre for Drug Research & Development), David Kwok (BRI Biopharmaceutical Research Inc.), Shyh-Dar Li (UBC), Larry Lynd (UBC), Corey Nislow (UBC), Simon Pimstone (Xenon Pharmaceuticals Inc.), Robert Young (Simon Fraser University) Staff: Bev Berekoff Barbara Scollick From Drug Discovery to Health Outcomes: Population to Patient | 1s Conference Program TUESDAY, MAY 31, 2016 8:00 AM Registration 9:00 - 5:00 Industry Day: Innovation and Management of Modern Pharmaceuticals (Whistler Ballroom B) 9:00 - 10:00 PLENARY 1: Carolyn Buser-Doepner, GSK New Trends in Pharma-Academia Collaborations for Drug Discovery Chair: Amyn Sayani, GSK SPONSORED BY: COLORCON 10:00-10:15 Refreshment and networking break Showcasing Drug Discovery Companies 10:15 - Chair: Jason Crawford, CDRD 11:00 Robin Sherrington, Xenon Pharmaceuticals Human Channelopathies: Providing Key Insights Into Drug Development Ernie McEachern, Alectos Therapeutics Alectos Therapeutics: Targeted Innovation in Preclinical Drug Discovery Novel Delivery Technologies for Therapeutics 11:00 - Chair: Pieter Cullis, UBC 12:30 John Babcook, Zymeworks Inc. Zymelink™ - Next Generation Drug Conjugates James Taylor, Precision Nanosystems The NanoAssemblr Platform: Microfluidic-based Manufacture of Nanomedicines from uLs to 10s L Michael Hope, Acuitas Therapeutics A Lipid Nanoparticle Platform to Enable mRNA Therapeutics 12:30 - 1:30 Lunch break and networking 1:30 - 2:30 Pharma at the Forefront in Drug Discovery Chair: Robert Young, SFU Jennifer Yearley, Merck Research Labs Translational Biology in the IO Space - Patient Response, Combination Therapies, New Approaches Anne Fourie, Janssen Pharmaceutical Research & Development Psoriasis - From Transformational Treatments to Cure and Interception 2:30 - 3:00 Refreshment and networking break New Commercialization Strategies, Regulatory Challenges, Big Data Issues 3:00 - 4:30 Chair: Jason Crawford, CDRD David Main, Aquinox, & Chair BIOTECanada New Commercialization Strategies Farzad Ali, Pfizer Access to New Medicines, Do Canadians Deserve Better? Paul Terry, PHEMI Health Systems Privacy, Governance & Innovation in the Era of Big Data 4:30 - 5:30 Closing Plenary: Chris Halyk, President, Janssen Inc. Are Innovative Medicines and our Life Sciences Industry at Risk in Canada? Chair: Catherine Lau, Janssen Inc. 5:30 - 7:00 Welcome Reception: CSPS, CC-CRS, AFPC SPONSORED BY JANSSEN INC. 2s | CSPS/CC-CRS Conference 2016, Vancouver, BC, Canada WEDNESDAY, JUNE 1 - MORNING SESSIONS 7:00 AM Registration and Poster Set-Up 7:30 - Trainee Mentoring Breakfast 9:00 9:00 - PLENARY LECTURE: Aaron Schimmer, Princess Margaret Cancer Centre 10:00 New Therapeutic Strategies to Target the Mitochondria in Leukemia Chair: Corey Nislow, UBC 10:00 - Refreshment Break: Posters, Exhibitors, and Networking (Theatre) 10:30 10:30 - SESSION 1: Special Populations SPONSORED BY: SANDOZ CANADA 12:00 Chair: Abby Collier, UBC SESSION 2: Regulatory Challenges and Opportunities Chair: Fakhreddin Jamali, University of Alberta (Whistler Ballroom A) (Whistler Ballroom B) 10:30 Pediatric Development of Metabolizing Enzymes Regulatory Issues on the Determination of Abby Collier, University of British Columbia Bioequivalence for Modified-Release Drug Products with Multiphasic Concentration Profiles Laszlo Endrenyi, Faculty of Medicine, University of Toronto 11:00 PBPK Modelling and Simulation in Pediatric Drug Current Status of Decision-making for Biosimilars in Development Canada Andrea Edginton, University of Waterloo Agnes Klein, Biologics and Genetics Therapy Directorate, Health Canada 11:30 Developmental Pharmacology – ADME Consequences in Challenges in Ensuring Drug Product Quality in the Children Product Lifecycle Catherijne Knibbe, Universiteit Leiden Krishnan Tirunellai, Therapeutic Products Directorate, Health Canada 12:00 - GSK/CSPS Early Career Award Lecture 12:30 Mary De Vera, UBC Patient Engagement in Medication Adherence Research Chair: Larry Lynd, UBC 12:30 - Lunch break 2:00 Posters, Exhibitors, and Networking (Theatre) From Drug Discovery to Health Outcomes: Population to Patient | 3s WEDNESDAY, JUNE 1 - AFTERNOON SESSIONS 2:30 - SESSION 3: Nanomedicines Become Personal: SESSION 4: Broaching the Fourth Hurdle: Getting 5:10 Opportunities and Challenges Drugs on the Formulary Co-Chairs: Shyh-Dar Li, UBC, and Amy Lee, Arbutus Chair: Larry Lynd, UBC Biopharma (Whistler Ballroom B) (Whistler Ballroom A) 2:30 Image-guided Focused Ultrasound for Targeted Delivery (2:30) Orphan Drugs-Catastrophic Drug Coverage of Drugs Fred Horne, Horne and Associates Kullervo Hynynen, Sunnybrook Res. Institute 3:00 Personalize Nanomedicines by Developing (2:45) Developing Specialty Drugs for a Conditional Multifunctional Nanoparticles and Identifying Reimbursement Environment: Is Quicker Necessarily Therapeutic Biomarkers Better? Shyh-Dar Li, UBC Chris McCabe, University of Alberta 3:30 Refreshment Break: Posters, Exhibitors, and Networking (Theatre) 4:00 Porphysome Nanotechnology: Discovery and Road to (3:00) Perspectives from a Public Drug Plan on the Clinical Translation Challenges and Opportunities with Expensive Drugs for Gang Zheng, Ontario Cancer Institute Rare Diseases (EDRD) Eric Lun, B.C. Ministry of Health (3:15) The Complexity in Making Reimbursement 4:30 TKM-Ebola and TKM-Ebola-Guinea: Rapid Re- Decisions around Expensive Drugs for Rare Diseases development of a Nucleic Acid Therapeutic in Response Doug Coyle, University of Ottawa to the West Africa Outbreak Amy Lee, Arbutus Biopharma Corporation (4:00 - 5:00) Panel Discussion 5:00 - Oral Presentation from Posters: Oral Presentation from Posters: 5:15 Polymer-Lipid Based Nanomedicine of Synergistic Drug Preferences for Donating Money to Support Drug Combination for Improving Chemotherapy of Multidrug Development Research Projects in a Sample of Resistant Breast Cancer Canadian and U.S. Adults Rui Xue Zhang, University of Toronto Nick Dragojlovic, University of British Columbia 5:15 - Posters, Exhibitors, and Networking (Theatre) 6:00 4s | CSPS/CC-CRS Conference 2016, Vancouver, BC, Canada THURSDAY, JUNE 2 - MORNING SESSIONS 7:00 AM Registration and Poster Set-up 7:30 - Breakfast Lectures: Medical Marijuana 9:00 Chair: Frank Abbott, UBC Jonathan Page, UBC Chemical and Genomic Analysis of Cannabis Caroline MacCallum, Greenleaf Medical Clinic, & UBC Hospital Medical Clinic, Vancouver Medical Cannabis and Cannabinoids 9:00 - PLENARY LECTURE: Ivana Cecic , Genome BC 10:00 Genomics in Canada: From Knowledge Generation to Patient Outcomes Chair: Corey Nislow, UBC 10:00-- Refreshment Break: Posters, Exhibitors, and Networking (Theatre) 10:30 BREAK SPONSORED BY MSFHR 10:30 - SPONSORED BY: GENOME BC SESSION 6: Responsive Drug Delivery Systems 12:00 SESSION 5: Pharmacogenomics in the Clinic and Community Co-Chairs: Todd Hoare, McMaster University and Marc Gauthier, INRS Chair: Corey Nislow, UBC (Whistler Ballroom A) (Whistler Ballroom B) (10:30-10:40) Trainee Presentation: Complete 10:30 Harnessing the Power of Synthetic Lethality: Regression of Xenograft Tumors upon Targeted Delivery Identifying and Targeting Dependencies in Cancer of Paclitaxel via Π-Π Stacking Stabilized Polymeric Lisa Belmont, Genentech Micelles Roy van der Meel, Utrecht University / UBC Smart Automated Release, Because Drugs Don't Work in Patients who Don't Take Them Adah Almutairi, University of California, San Diego 11:00 Implementation of Pharmacogenomics for the Poly(2-oxazoline) Biomaterials Prevention of Severe Adverse Drug Reactions in Richard Hoogenboom, Ghent University, Belgium Pediatric Oncology Colin Ross, UBC and CFRI 11:30 UBC - GenomeBC - BCPhA Project "Bio-hybrid" Therapeutics Corey Nislow, UBC Marc Gauthier, Institut National de la Recherche Scientifique (INRS) 12:00 - CSPS Lifetime Achievement Award Lecture 12:30 Fakhreddin Jamali, University of Alberta Pharmaceutical Research and Development, Lessons Learned Chair: Raimar Loebenberg (Whistler Ballroom A) 12:30 - 12:30 - Annual Meetings: CSPS (Ballroom A) & CC-CRS (Ballroom B) 2:30 Lunch Break Posters, Exhibitors, and Networking (Theatre) From Drug Discovery to Health Outcomes: Population to Patient | 5s THURSDAY, JUNE 2 - AFTERNOON SESSIONS 2:30 - SPONSORED BY: ZYMEWORKS SESSION 8: Health Sustainability SESSION 9: JOINT Session with 5:00 Evidence AFPC SESSION 7: Drug Targeting and Targeting Drugs Chair: Mark Harrison, UBC Chair: Simon Albon, UBC Chair: Robert Young, SFU (Whistler Ballroom A) (Whistler Ballroom B) (Fraser Room) 2:30 Targeted and Stimuli-sensitive Role of Patient Reported Outcome Integrating Pharmaceutical Combination siRNA/Drug Measures (PROMs) in the Ongoing Sciences into a Pharm D Curriculum Nanopreparations for Multidrug Evaluation of Treatment and Scott Singleton, The University of Resistant Cancer Reimbursement North Carolina at Chapel Hill Vladimir Torchilin, Northeastern Stirling Bryan, UBC/Centre for University Clinical Epidemiology & Evaluation (C2E2) Roundtable Discussion 3:00 Advancements in Antibody Drug Patient Reported Outcome Conjugate Technology Measures (PROMs) and Patient Django Sussman, Seattle Genetics, Decision Making Inc. Mark Harrison, UBC 3:30 Refreshment